108.14 -0.05 (-0.05%)
After hours: 5:51PM EDT
|Bid||106.75 x 1100|
|Ask||108.33 x 1100|
|Day's Range||107.53 - 108.48|
|52 Week Range||81.66 - 112.05|
|Beta (3Y Monthly)||0.49|
|PE Ratio (TTM)||33.18|
|Earnings Date||Nov 19, 2019|
|Forward Dividend & Yield||2.16 (2.01%)|
|1y Target Est||117.65|
Align Technology (ALGN) is continuing with its winning streak of delivering a sturdy Invisalign Technology volume expansion across the company's entire customer base.
Apart from the decent number of new jobs, the unemployment rate in the United States dropped 0.2 percentage points to hit a five-decade low of 3.5% last month.
Is Medtronic plc (NYSE:MDT) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. […]
Medtronic's (MDT) filing for both its InterStim products to gain FDA's PMA is its essential bid to boost its Pelvic Health & Gastric Therapies business.
DUBLIN, Oct. 09, 2019 -- Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) has classified the company’s voluntary field action initiated in.
Stratasys' (SSYS) new 3D printer is especially beneficial for medical device companies, which require new ways to drive faster adoption of technologies and procedures.
This FDA designation is expected to bolster Medtronic's (MDT) Aortic, Peripheral & Venous line within the broader Cardiac and Vascular group.
Medtronic plc (MDT) today announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Valiant® TAAA Stent Graft System for minimally invasive repair of thoracoabdominal aortic aneurysm (TAAA). A TAAA is a complex condition causing a bulging of the aorta, which extends from the chest down into to the abdomen.
When Medtronic plc's (NYSE:MDT) announced its latest earnings (26 July 2019), I wanted to understand how these figures...
DUBLIN, Oct. 07, 2019 -- Medtronic plc (NYSE:MDT) today announced the start of a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter.
Smaller, Rechargeable Device Will Provide More Choices for Patients Suffering with Bladder and Bowel Control Issues SureScan™ MRI Leads Will Provide Full-Body MRI.
The "father of robotic surgery" believes the machines used in surgery today will be considered quite primitive not too far into the future.
“You’re not going to find a whole lot of other funds in the Southeast that have [a musculoskeletal focus]. … And, there’s not a life sciences industry to speak of in Nashville or even Atlanta.”
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the […]
Sturdy domestic sales along with a strong rollout of the t:slim X2 Insulin Pump in the international markets bode well for Tandem Diabetes (TNDM).